Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Epidemiology and Community Health
|
January 24, 2023
Austerity, economic hardship and access to medications: a repeated cross-sectional population survey study, 2013-2020
Katri Aaltonen
Social Science & Medicine (1982)
|
March 22, 2024
Financial burden of medicines in five Northern European countries: A decommodification perspective
Katri Aaltonen, Maria Vaalavuo
Plos One
|
May 5, 2021
The effect of pharmaceutical co-payment increase on the use of social assistance-A natural experiment study
Hanna Rättö, Katri Aaltonen
BMC Health Services Research
|
December 5, 2024
Prescribing patterns before the initiation of novel antidiabetic medicines in public, occupational, and private healthcare: a register study reflecting the guidelines of care in type 2 diabetes
Hanna Rättö, Mikko Nurminen, Katri Aaltonen
Journal of Aging & Social Policy
|
May 5, 2024
The Effect of Informal Caregiving on Depression: An Asymmetric Panel Fixed-Effects Analysis of In-Home and Out-Of-Home Caregivers Across Europe
Andreas Nolan, Katri Aaltonen, Mirkka Danielsbacka
International Journal for Equity in Health
|
March 10, 2022
Citizens' opinions and experiences related to costs and reimbursements for medications in times of retrenchment: cross-sectional population surveys in 2015 and 2017
Katri Aaltonen, Mikko Niemelä, Irene Prix
European Journal of Clinical Pharmacology
|
August 1, 2015
Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study
Härkönen Mirva, Timonen Johanna, Tervola Jussi, et al.
Health Policy (Amsterdam, Netherlands)
|
June 3, 2021
The impact of a co-payment increase on the consumption of type 2 antidiabetics - A nationwide interrupted time series analysis
Hanna Rättö, Terhi Kurko, Jaana E Martikainen, et al.
Maturitas
|
June 18, 2014
From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012
Elisa Holm, Katri Aaltonen, Anna-Mari Heikkinen, et al.
Pharmacoeconomics
|
September 12, 2012
A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand
Rajan Ragupathy, Katri Aaltonen, June Tordoff, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Epidemiology and Community Health
|
January 24, 2023
Austerity, economic hardship and access to medications: a repeated cross-sectional population survey study, 2013-2020
Katri Aaltonen
Social Science & Medicine (1982)
|
March 22, 2024
Financial burden of medicines in five Northern European countries: A decommodification perspective
Katri Aaltonen, Maria Vaalavuo
Plos One
|
May 5, 2021
The effect of pharmaceutical co-payment increase on the use of social assistance-A natural experiment study
Hanna Rättö, Katri Aaltonen
BMC Health Services Research
|
December 5, 2024
Prescribing patterns before the initiation of novel antidiabetic medicines in public, occupational, and private healthcare: a register study reflecting the guidelines of care in type 2 diabetes
Hanna Rättö, Mikko Nurminen, Katri Aaltonen
Journal of Aging & Social Policy
|
May 5, 2024
The Effect of Informal Caregiving on Depression: An Asymmetric Panel Fixed-Effects Analysis of In-Home and Out-Of-Home Caregivers Across Europe
Andreas Nolan, Katri Aaltonen, Mirkka Danielsbacka
International Journal for Equity in Health
|
March 10, 2022
Citizens' opinions and experiences related to costs and reimbursements for medications in times of retrenchment: cross-sectional population surveys in 2015 and 2017
Katri Aaltonen, Mikko Niemelä, Irene Prix
European Journal of Clinical Pharmacology
|
August 1, 2015
Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study
Härkönen Mirva, Timonen Johanna, Tervola Jussi, et al.
Health Policy (Amsterdam, Netherlands)
|
June 3, 2021
The impact of a co-payment increase on the consumption of type 2 antidiabetics - A nationwide interrupted time series analysis
Hanna Rättö, Terhi Kurko, Jaana E Martikainen, et al.
Maturitas
|
June 18, 2014
From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012
Elisa Holm, Katri Aaltonen, Anna-Mari Heikkinen, et al.
Pharmacoeconomics
|
September 12, 2012
A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand
Rajan Ragupathy, Katri Aaltonen, June Tordoff, et al.
Page
of 2